Teleflex Announces Quarterly Dividend
Teleflex (NYSE: TFX) has announced a quarterly cash dividend of $0.34 per share of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teleflex (NYSE: TFX) has announced a quarterly cash dividend of $0.34 per share of common stock. The dividend will be payable on September 16, 2024, to shareholders of record at the close of business on August 15, 2024. This announcement demonstrates Teleflex's commitment to providing regular returns to its shareholders and maintaining its dividend policy. The declaration of a dividend can be seen as a positive signal of the company's financial health and confidence in its future prospects.
Positive
- Consistent dividend payment indicating financial stability
- Providing regular returns to shareholders
Negative
- None.
Details
News Market Reaction – TFX
The recorded move for TFX in the trading session of this news was +6.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents (
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.
Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investor.relations@teleflex.com
610-948-2836
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.